文献速递睡眠呼吸障碍

循环血浆细胞外微囊泡microRNA cargo与阻塞性睡眠呼吸暂停儿童内皮功能障碍

Circulating Plasma Extracellular Microvesicle MicroRNA Cargo and Endothelial Dysfunction in Children with Obstructive Sleep Apnea.
PubMed 文献 · Am J Respir Crit Care Med · 2016-01-01

该研究探讨肥胖及非肥胖儿童中阻塞性睡眠呼吸暂停(OSA)相关的循环外泌体miRNA是否可区分内皮功能状态。血浆外泌体主要来源于内皮细胞,并能重现内皮功能障碍(ED)表型;外泌体miRNA-630在ED儿童中表达降低,治疗后随内皮功能恢复而正常化,抑制miRNA-630可诱导ED表型,其调控416个基因靶点包括Nrf2、AMPK和紧密连接通路。

要点

  • OSA儿童血浆外泌体miRNA特征可区分内皮功能障碍与正常内皮功能。
  • 外泌体miRNA-630在ED儿童中降低,治疗后随内皮功能恢复而正常化。
  • 抑制miRNA-630可诱导内皮功能障碍表型,其调控Nrf2、AMPK及紧密连接通路。

核心结论

  • 外泌体miRNA-630可能是OSA和/或肥胖儿童血管功能及心血管疾病风险的潜在关键介质,并可作为治疗靶点。

研究设计与样本

  • 招募肥胖儿童(BMI z评分>1.65)和非肥胖儿童,进行多导睡眠监测(PSG),次日晨采血测内皮功能并分离血浆外泌体。
  • 将外泌体与内皮细胞单层共孵育,用电细胞-基底阻抗传感系统评估内皮屏障破坏,并行紧密连接蛋白免疫荧光评估。
  • 应用miRNA和mRNA芯片分析外泌体及内皮细胞,转染miRNA抑制剂和模拟物进行机制实验。

主要发现

  • 肥胖或非肥胖OSA儿童的血浆外泌体主要来源于内皮细胞,可在体外和注射小鼠体内重现ED或正常内皮功能。
  • 芯片分析识别出可区分ED与正常内皮功能的有限外泌体miRNA特征。
  • ED儿童外泌体miRNA-630表达降低,治疗后随内皮功能恢复而正常化。
  • 将无ED受试者的外泌体转染miRNA-630抑制剂可诱导ED功能表型。
  • miRNA-630调控内皮细胞中416个基因靶点,包括Nrf2、AMPK和紧密连接通路。

临床怎么用

  • 外泌体miRNA-630有望作为儿童OSA相关内皮功能障碍的生物标志物及潜在治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE: Obese children are at increased risk for developing obstructive sleep apnea (OSA), and both of these conditions are associated with an increased risk for endothelial dysfunction (ED) in children, an early risk factor for atherosclerosis and cardiovascular disease. Although weight loss and treatment of OSA by adenotonsillectomy improve endothelial function, not every obese child or child with OSA develops ED. Exosomes are circulating extracellular vesicles containing functional mRNA and microRNA (miRNA) that can be delivered to other cells, such as endothelial cells. OBJECTIVES: To investigate whether circulating exosomal miRNAs of children with OSA differentiate based on endothelial functional status. METHODS: Obese children (body mass index z score >1.65) and nonobese children were recruited and underwent polysomnographic testing (PSG), and fasting endothelial function measurements and blood draws in the morning after PSG. Plasma exosomes were isolated from all subjects. Isolated exosomes were then incubated with confluent endothelial cell monolayer cultures. Electric cell-substrate impedance sensing systems were used to determine the ability of exosomes to disrupt the intercellular barrier formed by confluent endothelial cells. In addition, immunofluorescent assessments of zonula occludens-1 tight junction protein cellular distribution were conducted to examine endothelial barrier dysfunction. miRNA and mRNA arrays were also applied to exosomes and endothelial cells, and miRNA inhibitors and mimics were transfected for mechanistic assays. MEASUREMENTS AND MAIN RESULTS: Plasma exosomes isolated from either obese children or nonobese children with OSA were primarily derived from endothelial cell sources and recapitulated ED, or its absence, in naive human endothelial cells and also in vivo when injected into mice. Microarrays identified a restricted signature of exosomal miRNAs that readily distinguished ED from normal endothelial function. Among the miRNAs, expression of exosomal miRNA-630 was reduced in children with ED and normalized after therapy along with restoration of endothelial function. Conversely, transfection of exosomes from subjects without ED with an miRNA-630 inhibitor induces the ED functional phenotype. Gene target discovery experiments further revealed that miRNA-630 regulates 416 gene targets in endothelial cells that include the Nrf2, AMP kinase, and tight junction pathways. CONCLUSIONS: These observations elucidate a novel role of exosomal miRNA-360 as a putative key mediator of vascular function and cardiovascular disease risk in children with underlying OSA and/or obesity, and identify therapeutic targets.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Khalyfa A, Kheirandish-Gozal L, Khalyfa AA, et al. Circulating Plasma Extracellular Microvesicle MicroRNA Cargo and Endothelial Dysfunction in Children with Obstructive Sleep Apnea. Am J Respir Crit Care Med. 2016. PMID: 27163713

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。